The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: A revealed preferences analysis of recommendations of the pan-Canadian Oncology Drug Review 2011–2017

Search results

• Cleaned pCODR decision summaries

  Skedgel, C. (Creator), Figshare, 5 Jan 2018

  DOI: 10.6084/m9.figshare.5759646.v1

  Dataset